[Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000494:pharmacology; D006949:Hyperlipidemias / Q000097:blood*; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D051381:Rats; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
Acción del etofibrato [2 (nicotinoiloxi) etil-p-clorofenoxiisobutirato] sobre el metabolismo lipídico. I. Efectos sobre los lípidos séricos en ratas normales e hiperlipidémicas.